Glucose monitor test for heart attack recovery
Part of Heart & circulation clinical trials.
This study tests a continuous glucose monitor (FSL Pro iQ) in people with heart attack to see if blood sugar patterns can predict recovery. It may help doctors better manage your care after a heart attack.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart attack (STEMI or NSTEMI) and are in a cardiac intensive care unit.
- You are not in shock from heart failure or infection.
- You are not pregnant or breastfeeding.
- You are willing and able to give written consent.
- You are not currently in another research study that might affect outcomes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a way of checking blood sugar closely after an acute coronary event (a heart-related emergency) in people with type 2 diabetes. It may help doctors understand the best monitoring approach to improve safety and care during recovery.
This study uses a continuous glucose monitor to help people with prediabetes or type 2 diabetes better manage their blood sugar and weight, and will test how well it works in a real-world workplace setting.
This study uses a continuous glucose monitor (a small sensor that tracks blood sugar levels) in people who have had a stroke and also have type 2 diabetes. The goal is to see how well the monitor works and if it helps manage blood sugar after a stroke.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This trial tests whether using a continuous glucose monitor (CGM) helps people with both heart failure and diabetes manage their blood sugar better. It follows patients from hospital admission through discharge.
This study compares a continuous glucose monitor (a small sensor on the skin) with the usual fingerstick method for checking blood sugar in hospitalized patients. It aims to see if the sensor is more convenient and just as accurate.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.